Results 71 to 80 of about 13,606 (212)

Sarcopenic Obesity Phenotype Index (SOPi): A Population‐Based Study

Journal of Cachexia, Sarcopenia and Muscle, Volume 16, Issue 5, October 2025.
ABSTRACT Background Sarcopenic obesity (SO) is a clinical condition defined by the coexistence of high body fat mass and low muscle function and mass, which increases the risk of adverse health outcomes, including disability and mortality. Early detection and frequent monitoring of SO are essential for preventive interventions and management strategies.
Elizabeth Benz, Alexandre Pinel, Christelle Guillet, Frederic Capel, Bruno Pereira, Dimitris Rizopoulos, Alfonso J. Cruz‐Jentoft, Doris Eglseer, Eva Topinkova, Rocco Barazzoni, Lorenzo M. Donini, Fernando Rivadeneira, Marinka Steur, Trudy Voortman, Peter J. M. Weijs, Josje D. Schoufour, Yves Boirie   +16 more
wiley   +1 more source

High Prevalence of Psychological Symptoms, Sexual Dysfunction, and Prolonged Medical Leave Two Years After Acute Leukemia Diagnosis—Patient Reported Outcome in Sweden

eJHaem, Volume 6, Issue 5, October 2025.
ABSTRACT Introduction With the purpose of identifying unmet needs of patients with acute leukemia, survivors were identified from the Swedish National Acute Leukemia registries. Methods At six months and at two years from diagnosis, patients were requested by mail to report outcome with focus on depression, sick leave, and sexual dysfunction.
Emma Bergfelt Lennmyr, Anna Lübking, Marie Abrahamsson, Gunnar Juliusson, Martin Höglund, Heléne Hallböök   +5 more
wiley   +1 more source

Do antidepressants prevent suicide? [PDF]

, 2006
antidepressive agents; drug discontinuation; pharmacoepidemiology ...
Kvist, Tine Kajsa, Andersen, Per Kragh, Søndergård, Lars, Kessing, Lars Vedel   +3 more
core  

Antidepressant use and the components of the frailty syndrome

Revista Brasileira de Geriatria e Gerontologia, 2018
Objective: to evaluate the effects of antidepressant use on components of frailty. Methods: a cross-sectional and analytical study comparing groups of users and non-users of antidepressants was carried out in a municipal region in the south of Brazil ...
Vanessa Adelina Casali Bandeira, Evelise Moraes Berlezi, Carolina Baldissera Gross, Christiane de Fátima Colet   +3 more
doaj   +2 more sources

Lithium Augmentation in Treatment‐Resistant Depression: A Qualitative Review of the Literature

Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, Volume 45, Issue 10, Page 688-701, October 2025.
ABSTRACT Depression is the leading cause of disability worldwide, affecting people of all ages. Both pharmacological and non‐pharmacological therapies are available for its treatment. However, some patients do not respond to first‐line pharmacological interventions, referred to as treatment‐resistant depression (TRD).
Angela Acero‐González, Yahira Guzman, Nadia Juliana Proaños, Rosa‐Helena Bustos, María Aconcha, Ivan Guerrero, Laura Alejandra Martinez, Michael Berk, Seetal Dodd   +8 more
wiley   +1 more source

The Effect of ABCB1 Polymorphisms on the Efficacy of Antidepressants

Basic &Clinical Pharmacology &Toxicology, Volume 137, Issue 4, October 2025.
ABSTRACT This scoping review investigates the association between ABCB1 polymorphisms and antidepressant efficacy in humans. A systematic search identified 630 records, of which 58 met the inclusion criteria, resulting in 42 unique studies (five randomised controlled trials (RCTs), two randomised studies (non‐RCTs), 30 prospective cohort studies, three
Sofie Voss Thorsen, Cille Bülow, Kim Dalhoff, David Peick Sonne   +3 more
wiley   +1 more source

Association Between Depression and Risk of Hypertension: A Systematic Review and Meta‐Analysis

Brain and Behavior, Volume 15, Issue 9, September 2025.
This meta‐analysis of 36 studies shows a significant link between depression and hypertension risk (OR = 1.198, 95% CI: 1‐086‐1.321; HR = 1.277, 95% CI: 1.159‐1.408). It advocates for mental health screening in cardiovascular care. ABSTRACT Background Hypertension and depression are major global health concerns, with increasing evidence suggesting a ...
Prakasini Satapathy, Abhay M. Gaidhane, Nasir Vadia, Soumya V. Menon, Kattela Chennakesavulu, Rajashree Panigrahi, Ganesh Bushi, Mahendra Singh, Sanjit Sah, Awakash Turkar, S. Govinda Rao, Khang Wen Goh, Muhammed Shabil, Edward Mawejje   +13 more
wiley   +1 more source

Depression and cognition in type 2 diabetes : From a life course perspective [PDF]

, 2011
Väitöskirja, liitteenä alkuperäisartikkelit (ei verkkoversiossa)ei tietoa saavutettavuudesta unknown ...
Paile-Hyvärinen, Maria
core  

Pharmacogenetics of antidepressive drugs: a way towards personalized treatment of major depressive disorder [Az antidepresszívumok farmakogenetikája: a major depresszív zavar személyre szabott kezelése felé] [PDF]

, 2015
Major depressive disorder is one of the most prevalent psychiatric disorders, and in spite of extensive ongoing research, we neither fully understand its etiopathological background, nor do we possess sufficient pharmacotherapeutic tools to provide ...
Gonda Xénia, Faludi Gábor, Döme Péter, Weizman S   +3 more
core  

Antidepressive Medikation bei Patienten mit kardiovaskulären Erkrankungen [PDF]

, 2004
Infolge der demographischen Entwicklung wird die Komorbidität von depressiven Störungen mit kardiovaskulären Erkrankungen zunehmend an Bedeutung gewinnen.
Hoff, P., U. Meincke, Hoff, Paul; https://orcid.org/, Meincke, Ulrich, P. Hoff   +4 more
core   +1 more source